Literature DB >> 1864966

Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.

A S Petrides1, L C Groop, C A Riely, R A DeFronzo.   

Abstract

Insulin secretion and insulin sensitivity were evaluated in eight clinically stable cirrhotic patients and in 12 controls. OGTT was normal in cirrhotics but plasma insulin response was increased approximately twofold compared with controls. Subjects received a three-step (0.1, 0.5, 1.0 mU/kg.min) euglycemic insulin clamp with indirect calorimetry, [6-3H]-glucose, and [1-14C]-palmitate. During the two highest insulin infusion steps glucose uptake was impaired (3.33 +/- 0.31 vs. 5.06 +/- 0.40 mg/kg.min, P less than 0.01, and 6.09 +/- 0.50 vs. 7.95 +/- 0.52 mg/kg.min, P less than 0.01). Stimulation of glucose oxidation by insulin was normal; in contrast, nonoxidative glucose disposal (i.e., glycogen synthesis) was markedly reduced. Fasting (r = -0.553, P less than 0.01) and glucose-stimulated (r = -0.592, P less than 0.01) plasma insulin concentration correlated inversely with the severity of insulin resistance. Basal hepatic glucose production was normal in cirrhotics and suppressed normally with insulin. In postabsorptive state, plasma FFA conc (933 +/- 42 vs. 711 +/- 44 mumol/liter, P less than 0.01) and FFA turnover (9.08 +/- 1.20 vs. 6.03 +/- 0.53 mumol/kg.min, P less than 0.01) were elevated in cirrhotics despite basal hyperinsulinemia; basal FFA oxidation was similar in cirrhotic and control subjects. With low-dose insulin infusion, plasma FFA oxidation and turnover failed to suppress normally in cirrhotics. During the two higher insulin infusion steps, all parameters of FFA metabolism suppressed normally. In summary, stable cirrhotic patients with normal glucose tolerance exhibit marked insulin resistance secondary to the impaired nonoxidative glucose disposal. Our results suggest that chronic hyperinsulinism may be responsible for the insulin resistance observed in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864966      PMCID: PMC295386          DOI: 10.1172/JCI115340

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  62 in total

1.  Oxidation of plasma FFA in lean and obese humans.

Authors:  B Issekutz; P Paul; H I Miller; W M Bortz
Journal:  Metabolism       Date:  1968-01       Impact factor: 8.694

2.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

Authors:  G I Shulman; D L Rothman; T Jue; P Stein; R A DeFronzo; R G Shulman
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

3.  Use of a variable tracer infusion method to determine glucose turnover in humans.

Authors:  J M Molina; A D Baron; S V Edelman; G Brechtel; P Wallace; J M Olefsky
Journal:  Am J Physiol       Date:  1990-01

4.  The effect of growth hormone on glucose metabolism and insulin secretion in man.

Authors:  P R Bratusch-Marrain; D Smith; R A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

5.  No evidence for isotope discrimination of tritiated glucose tracers in measurements of glucose turnover rates in man.

Authors:  V A Koivisto; H Yki-Järvinen; I Puhakainen; A Virkamäki; J Kolaczynski; R DeFronzo
Journal:  Diabetologia       Date:  1990-03       Impact factor: 10.122

6.  Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis.

Authors:  J Bosch; R Gomis; D Kravetz; R Casamitjana; J Terés; F Rivera; J Rodés
Journal:  Am J Physiol       Date:  1984-09

7.  Total and individual free fatty acid concentrations in liver cirrhosis.

Authors:  O Riggio; M Merli; A Cantafora; A Di Biase; L Lalloni; F Leonetti; P Miazzo; V Rinaldi; F Rossi-Fanelli; G Tamburrano
Journal:  Metabolism       Date:  1984-07       Impact factor: 8.694

8.  Effect of fatty acids on glucose production and utilization in man.

Authors:  E Ferrannini; E J Barrett; S Bevilacqua; R A DeFronzo
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Operation of Randle's cycle in patients with NIDDM.

Authors:  S Bevilacqua; G Buzzigoli; R Bonadonna; L S Brandi; M Oleggini; C Boni; M Geloni; E Ferrannini
Journal:  Diabetes       Date:  1990-03       Impact factor: 9.461

10.  Insulin uptake by the human alcoholic cirrhotic liver.

Authors:  A Nygren; N Adner; L Sundblad; K L Wiechel
Journal:  Metabolism       Date:  1985-01       Impact factor: 8.694

View more
  21 in total

1.  Viruses and diabetes: is there something sweet about hepatitis C infection?

Authors:  A L Mason; G J Alexander
Journal:  Ochsner J       Date:  2001-07

2.  Metabolic effects of liver transplantation in cirrhotic patients.

Authors:  L Luzi; G Perseghin; E Regalia; L P Sereni; A Battezzati; D Baratti; E Bianchi; I Terruzzi; H Hilden; L C Groop; A Pulvirenti; M R Taskinen; L Gennari; V Mazzaferro
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 3.  Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

Review 4.  Metabolism of energy-yielding substrates in patients with liver cirrhosis.

Authors:  M J Müller; K H Böker; O Selberg
Journal:  Clin Investig       Date:  1994-08

5.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

Authors:  E Bugianesi; A Gastaldelli; E Vanni; R Gambino; M Cassader; S Baldi; V Ponti; G Pagano; E Ferrannini; M Rizzetto
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

Review 6.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

7.  Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism.

Authors:  O Selberg; W Burchert; J vd Hoff; G J Meyer; H Hundeshagen; E Radoch; H J Balks; M J Müller
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 8.  Viewpoints on the way to a consensus session: where does insulin resistance start? The liver.

Authors:  Gianluca Perseghin
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

9.  Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor Jesús Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

10.  Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma.

Authors:  K Saito; S Inoue; T Saito; S Kiso; N Ito; S Tamura; H Watanabe; H Takeda; H Misawa; H Togashi; Y Matsuzawa; S Kawata
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.